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Although ﬂaviviruses encode their own helicases, evidence suggests that cellular helicases are also
required for replication and/or assembly of these viruses. By and large, the mechanisms of action for
viral and cellular helicases are not known. Moreover, in some cases, enzymatic activity is not even
required for their roles in virus biology. Recently, we showed that expression of the host nucleolar
helicase DDX56 is important for infectivity of West Nile virus (WNV) particles. In the present study, we
demonstrate that the helicase activity of this enzyme is essential for its role in assembly of infectious
WNV virions. Over-expression of the capsid-binding region of DDX56 also reduces infectivity of WNV
suggesting that interaction of DDX56 and capsid protein is an important step in the virion assembly
pathway. To our knowledge, this is the ﬁrst study showing that enzymatic activity of a cellular helicase
is critical for infectivity of ﬂaviviruses.
Crown Copyright & 2012 Published by Elsevier Inc. All rights reserved.Introduction
West Nile virus (WNV) is an important human pathogen that
can cause severe neurological disease (reviewed in Brinton, 2002).
It is wide spread throughout the globe and is maintained in an
enzootic cycle with birds serving as the main reservoir. Similar to
most other ﬂaviviruses, mosquito-borne transmission is the main
mode of human infection. Currently, there are no WNV-speciﬁc
vaccines or therapies that are approved for use in humans.
As with all viruses, WNV is an obligate intracellular parasite
that is completely dependent upon the host cell for viral entry,
replication, assembly and egress. A recent study revealed that
more than 300 human genes are required for replication of WNV
and the closely related ﬂavivirus, Dengue virus (Krishnan et al.,
2008). In addition to replication, we anticipate that many other
human genes are needed for assembly and secretion of nascent
WNV virions. Rather than conducting genome-wide screens
to identify host factors that are involved in WNV biology, we
focused on cellular proteins that interact with the capsid protein.012 Published by Elsevier Inc. All
iology University of Alberta,
6G 2H7.
bman).In addition to performing a critical structural role in virus
assembly, our data indicate that interactions between this viral
protein and the milieu of host proteins may contribute to
pathogenesis (Hunt et al., 2007; van Marle et al., 2007). As well
as potentially functioning in a negative capacity at the virus-host
interface, interaction of WNV capsid with host proteins may be
required for replication and/or virus assembly. With respect to
the latter, we recently identiﬁed the nucleolar helicase DDX56 as
a WNV capsid-binding protein (Xu et al., 2011).
Expression of DDX56 is not required for virus replication and
thus could not have been identiﬁed in an RNAi screen designed
to identify host factors that function in this process. However,
expression of the nucleolar helicase DDX56 is important for
infectivity of WNV virions (Xu et al., 2011). Findings from other
laboratories indicate that both cellular and viral helicases play
critical roles in the biology of ﬂaviviruses (Ariumi et al., 2007;
Krishnan et al., 2008; Mamiya and Worman, 1999; Owsianka and
Patel, 1999; You et al., 1999). Accordingly, considerable efforts
have been directed toward determining the feasibility of targeting
cellular and viral helicases as a means to block viral infections
(Geiss et al., 2009; Kwong et al., 2005; Maga et al., 2011;
Stankiewicz-Drogon et al., 2010).
To aid in development of anti-viral therapies that target RNA
helicases which are integral to ﬂavivirus biology, it is critical torights reserved.
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evidence suggests that some RNA helicases are required for
replication of viral RNA whereas others are needed for assembly
of infectious virus particles. In addition to serving as co-factors
during virus replication and assembly, the mechanism by which
a given helicase functions in these processes may vary consider-
ably. Moreover, in some cases the enzymatic activity of a helicase
may not even be required for its role in the infection pathway. For
example, the helicase activity of the NS3 protein is dispensable for
its function assembly of infectious yellow fever virions (Patkar
and Kuhn, 2008).
In the present study, we investigated the mechanism by which
the nucleolar helicase DDX56 functions in morphogenesis of WNV
virions. Our data show that inactivating mutations in the DEAD
box motif of DDX56 impair its role in production of infectious
WNV virions. Similarly, over-expression of the capsid-binding
region of DDX56 has a negative impact on WNV infectivity.
Together, these ﬁndings are consistent with a scenario in which
the interaction between catalytically active DDX56 and the WNV
capsid protein is an important step during packaging genomic
RNA into nascent virions.Results
Construction of RNAi-resistant DDX56 mutants
As a ﬁrst step toward determining whether the enzymatic
activity of DDX56 is required for infectivity of WNV particles, we
constructed DDX56 mutants that lack helicase function. The
DEAD box motif is highly conserved in a subgroup of RNA
helicases (Schmid and Linder, 1992) and mutagenesis studies
have shown that substitution of asparagine for aspartate or
glutamine for glutamate results in complete loss of helicase
activity (Pause and Sonenberg, 1992). In addition to creating
D166N and E167Q mutations in DDX56, silent mutations were
introduced downstream of the DEAD box motif in an shRNA
target site (Fig. 1). The latter mutations allow the expression of
the DEAD box mutants in stable cell lines in which endogenous
levels of DDX56 have been reduced by RNA interference (Fig. 2A).
HEK293T cells stably expressing DDX56-speciﬁc or non-
silencing shRNAs were transduced with lentiviruses encoding
AcGFP and myc-tagged wild type DDX56 or DEAD box mutants.
Expression of the myc-tagged DDX56 proteins was monitored by
immunoblot analyses at 48 h post-transduction. Immunoblot
analyses show that compared to expression in non-silencing
(NS) cells, the level of wild type myc-tagged DDX56 (WT-RNAi-S)Fig. 1. Construction of RNAi-resistant forms of DDX56 with mutations in the DEAD box
were changed to asparagine (N) and glutamine (Q) to produce D166N and E167Q muta
sites to make the resulting constructs resistant to RNAi. All constructs contain a myc tin DDX56 knockdown cells was just on the threshold of detection
with the anti-myc antibody (Fig. 2B, lanes 3 and 9). In contrast,
the myc-tagged RNAi-resistant forms of wild type DDX56 as well
as the D166N and E167Q mutants were robustly expressed in the
DDX56 knockdown cells (Fig. 2B, lanes 10–12). These data demon-
strate that mutant versions of DDX56 are stable in a cellular
background in which endogenous DDX56 is depleted by RNAi.
DEAD box mutants are correctly targeted to the nucleolus
Next, it was important to demonstrate that the DEAD box
mutants were correctly targeted to the nucleolus similar to wild
type DDX56 (Zirwes et al., 2000). Mock- and WNV-infected A549
cells were transfected with plasmids encoding wild type or DEAD
box mutants of DDX56. As evidenced by colocalization with
nucleolin, both RNAi-sensitive and -resistant forms of myc-
tagged DDX56 are targeted to the nucleoli (Fig. 3). Similarly, the
DEAD box mutants D166N and E167Q localized to nuclei of A549
cells. These data conﬁrm that mutations in the DEAD box motif or
shRNA targeting sites within the DDX56 open reading frame do
not alter targeting of the helicase.
Helicase activity of DDX56 is important for infectivity of WNV
To determine whether enzymatic activity of DDX56 was
important for viral gene expression and/or infectivity of WNV,
DDX56 knockdown cells expressing RNAi-sensitive or resistant
forms of myc-tagged DDX56 proteins were infected with WNV.
At 48 h post-infection, cell lysates and supernatants were sub-
jected to immunoblot analyses and plaque assays, respectively.
The immunoblot in Fig. 4A shows that based on AcGFP expres-
sion, similar levels of transduction efﬁciency were achieved for
all of the DDX56 constructs. As expected, only the RNAi-resistant
forms of DDX56 were detected by immunoblotting with anti-
myc. In agreement with a recent report from our laboratory
(Xu et al., 2011), titers of WNV from DDX56 depleted cells
were reduced more than 100 fold compared to those from non-
silencing controls (Fig. 4B). However, infection of cells expres-
sing RNAi-resistant DDX56 resulted in normal viral titers, which
were well over 1108 pfu/ml. In contrast, infection of cells
expressing RNAi-sensitive DDX56 or DEAD box mutants pro-
duced viral titers that were similar to DDX56 knockdown cells
that had been transduced with a lentivirus encoding AcGFP only.
Capsid protein was efﬁciently co-immunoprecipitated with
D166N and E167Q mutants (Fig. 4C) and thus the failure of
these DEAD box mutants to complement the production ofmotif. Aspartate (D) and glutamate (E) residues in the DEAD box motif of DDX56
nts, respectively. In addition, silent mutations were introduced into siRNA-binding
ag at the C-terminus.
Fig. 2. Expression of RNAi-resistant DDX56 mutants. (A) Immunoblot analyses of DDX56 in stable HEK293T cell lines expressing DDX56-speciﬁc (KD-DDX56) or non-
silencing (NS) shRNAs. (B) The stable HEK293T cell lines were transduced with lentiviruses encoding normal (RNAi-sensitive) or RNAi-resistant versions of myc-tagged WT
and D166N and E167Q mutants. The lentiviruses also encode AcGFP, which is used to monitor transduction of cells. Forty-eight hours post-transduction, levels of
endogenous and myc-tagged DDX56 proteins were determined by immunoblotting.
Fig. 3. Mutations in the DEAD box active site of DDX56 do not affect targeting to the nucleolus. A549 cells were transfected with plasmids encoding myc-tagged wild type
(WT), D166N, and E167Q mutants as well as a vector. Twenty-four hours post-transfection, cells were infected with WNV (MOI¼5) for 24 h and then ﬁxed and processed
for indirect immunoﬂuorescence using mouse anti-myc, rabbit anti-nucleolin, and guinea pig anti-WNV capsid antibodies. Primary antibodies were detected using donkey
anti-mouse Alexa546, donkey anti-rabbit Alexa647 and goat anti-guinea pig Alexa488 secondary antibodies. Arrowheads indicate colocalization between capsid, DDX56
proteins and the nucleolar resident protein nucleolin. Nuclei were stained with DAPI. RNAi-sensitive (RNAi-S) and RNAi-resistant (RNAi-R) forms of WT and DDX56
mutants are indicated. Images were captured using a leica TCS SP5 confocal scanning microscope. Size bar ¼10 mm.
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capsid. Despite the large decrease (4100-fold) in viral titers,
expression of DEAD box mutants did not interfere withreplication of WNV. This conclusion is based on the observation
that levels of WNV capsid protein were normal in these cells
(Fig. 4A).
Fig. 4. Helicase activity of DDX56 is important for WNV infectivity. (A) DDX56 knockdown (KD-DDX56) and non-silencing (NS) stable HEK293T cells were transduced with
lentiviruses encoding myc-tagged DDX56 constructs that were RNAi resistant (RNAi-R) or sensitive (RNAi-S). Cells were then infected with WNV (MOI¼5) and at 48 h cell
lysates were analyzed by immunoblotting (upper panel). Relative amounts of capsid and AcGFP (normalized to actin) were quantitated (lower panel). (B) Levels of
infectious virus in the conditioned media of the transduced and infected cells were determined by plaque assays. (C) HEK293T cells were transfected with myc-tagged wt
and DEAD box mutants of DDX56. At 24 h post-transfection, cells were infected with WNV (MOI¼5) for 24 h and then whole-cell lysates (WCL) and mouse anti-myc
immunoprecipitates were subjected to SDS-PAGE and immunoblotting with mouse anti-myc or rabbit anti-WNV capsid antibodies.
Fig. 5. Helicase activity of DDX56 is important for packaging genomic RNA into WNV particles. (A) WNV virions were recovered from the conditioned media of infected
stable DDX56 knockdown (KD-DDX56) and non-silencing control (NS) HEK 293T cells by ultracentrifugation. The crude virion preparations were subjected to SDS-PAGE
and immunoblot analyses with rabbit anti-capsid antibody. The relative amounts of capsid from three independent experiments were quantitated. (B) Levels of
viral genomic RNA in the virions were determined by RT-PCR. The average relative levels of viral RNA (normalized to capsid protein) from three independent experiments
(each conducted in triplicate) were quantitated. Bars indicate standard error values.
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virions
Our recent studies suggest that DDX56 may function in packa-
ging viral genomic RNA into nascent virions (Xu et al., 2011). To
establish whether the helicase activity of DDX56 is important for
this process, we assayed the relative amounts of genomic RNA in
WNV particles secreted from cells expressing D166N and E167Q
mutants. Loss of DDX56 helicase activity did not affect expression
of WNV capsid protein (Fig. 4A) nor its secretion from infected cellsin the form of virus particles (Fig. 5A). To determine if packaging of
viral RNA was affected, total RNA was extracted from WNV
particles and the relative amounts of genomic RNA (normalized
to capsid protein) were determined by RT-PCR. Data in Fig. 5B
show that virus particles isolated from infected cells expressing
helicase dead mutants D166N and E167Q contained 3–4 times less
genomic RNA than those isolated from non-silencing cells or cells
expressing RNAi-resistant wild type DDX56. These data indicate
that the enzymatic activity of DDX56 is important for packaging
genomic RNA into WNV virions.
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infectivity of WNV
The data shown above together with results from our previous
study (Xu et al., 2011) are consistent with a scenario in which
interaction between WNV and catalytically active DDX56 plays an
important role in assembly of infectious virions. If this is indeed
the case, blocking interaction between capsid and DDX56 should
also reduce the yield of infectious WNV. Our approach was to
over-express the capsid-binding region of DDX56 in order to
prevent interaction of endogenous DDX56 with capsid. To identify
the region of DDX56 that binds to capsid, myc-tagged constructs
encoding the N- and C-terminal regions of DDX56 were co-
expressed with WNV capsid in transfected cells followed by
coimmunoprecipitation and immunoblotting. Data in Fig. 6 show
that in transfected or infected cells, the WNV capsid does not bind
to the DEAD box helicase-containing region of DDX56 (DDX56-
NT-myc), but rather, the C-terminal part of the protein, which was
produced in cells expressing DDX56-CT-myc. This region of
DDX56 also contains the targeting information that is required
for localization to the nucleolus (Fig. 7).
Next, lentiviruses encoding myc-tagged DDX56 N- and C-
terminal regions were used to transduce HEK293T cells, whichFig. 6. The C-terminus of DDX56 binds to the WNV capsid protein. (A) Structure and
C-terminal (CT) DDX56 constructs. (B) HEK293T cells were co-transfected with plasmid
levels of myc-tagged DDX56 proteins and capsid were determined in whole cell lysate
protein. In the right panel, cell lysates were subjected to immunoprecipitation followed
IgG light chain. (C) HEK293T cells were co-transfected with plasmids encoding GST-caps
relative levels of myc-tagged DDX56 proteins and capsid were determined in whole cel
the right panel, cell lysates were subjected to GST-pulldown followed by immunoblott
plasmids encoding DDX56 constructs and then infected with WNV. In the left panel, rela
lysates (WCL) by immunoblotting with antibodies to the myc epitope and WNV capsid
anti-capsid antibody followed by immunoblotting with antibodies to myc and capsid.were then infected with WNV. At 48 h post-infection, cell lysates
and culture supernatants were subjected to immunoblot and
plaque assays, respectively. Data in Fig. 8A show that expression
of full length, N- or C-terminal regions of DDX56 do not affect
viral gene expression based on the observation that similar levels
of capsid protein were detected in all of the infected cell lysates.
However, expression of DDX56-CT-myc reduced viral titers
approximately 50-fold compared to expression of full length
DDX56-myc or NT-DDX56-myc (Fig. 8B). While these results
suggest that interaction between WNV capsid and DDX56 is
important for a post-replication step in the WNV infection cycle,
assembly and secretion of WNV particles was not affected
(Fig. 8C). But the fact that signiﬁcantly less viral RNA was
detected in the virus particles is consistent with our hypothesis
that capsid-DDX56 interactions are important for incorporation
packaging viral genome.Discussion
Conventional antiviral therapies involve targeting virus-
encoded enzymes that are required for replication, processing of
polyproteins or viral egress from host cells. While there have beensize (amino acid residues) of myc-tagged wild type (WT), N-terminal (NT) and
s encoding DDX56 constructs with WNV capsid protein. In the left panel, relative
s (WCL) by immunoblotting with antibodies to the myc epitope and WNV capsid
by immunoblotting with antibodies to myc and capsid. The protein marked by n is
id together with WT, NT and CT DDX56 constructs or vector alone. In the left panel,
l lysates (WCL) by immunoblotting with antibodies to the myc epitope and GST. In
ing with antibodies to myc and GST. (D) HEK293T cells were co-transfected with
tive levels of myc-tagged DDX56 proteins and capsid were determine in whole cell
protein. In the right panel, cell lysates were subjected to immunoprecipitation by
Fig. 7. Nucleolar targeting information of DDX56 is contained in the C-terminal 329 amino acid residues. A549 cells were transfected with plasmids encoding myc-tagged
wild type (WT) DDX56, DDX56-NT or DDX56-CT. Twenty-four hours post-transfection, cells were infected with WNV (MOI¼5) for 24 h and then ﬁxed and processed for
indirect immunoﬂuorescence using mouse anti-myc, rabbit anti-nucleolin, and guinea pig anti-WNV capsid antibodies. Primary antibodies were detected using donkey
anti-mouse Alexa546, donkey anti-rabbit Alexa647 and goat anti-guinea pig Alexa488 secondary antibodies. Arrowheads indicate colocalization between capsid, DDX56
constructs and the nucleolar resident protein nucleolin. Nuclei are stained with DAPI. Images were captured using a leica TCS SP5 confocal scanning microscope.
Size bar¼10 mm.
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limitations. First, viruses almost invariably develop resistance to
these types of drugs. This is particularly true of RNA viruses
whose polymerases do not possess proof reading activity and are
therefore by nature, error prone and mutable. Second, the choice
of targets is very limited due to the small number of enzymes
encoded by most viruses. In contrast, targeting host factors as
means to control viral infection is a burgeoning area that has
shown promise, particularly for ﬂaviviruses. Replication and
assembly of infectious ﬂavivirus particles requires hundreds of
host genes (Krishnan et al., 2008). Accordingly, it may be possible
to target a variety of host proteins, particularly enzymes, as a
means to control viral infection. Although this approach may also
have drawbacks, viral resistance to small molecules that block
host enzymes should be minimal.
RNA helicases are one class of host enzymes that have been
proposed as anti-viral targets (Geiss et al., 2009; Kwong et al.,
2005; Maga et al., 2011; Stankiewicz-Drogon et al., 2010). Among
the helicase superfamily, DEAD box proteins form the largest
group of these enzymes. These helicases are thought to play
multiple roles in RNA metabolism including mRNA splicing and
transport, transcription, translation and remodeling of ribonu-
cleoprotein complexes. In most cases, the physiological substrates
of DEAD box helicases have not been deﬁned but it is clear that a
number of pathogenic RNA viruses require these enzymes for
replication and/or assembly. For example, at least two cellular
helicases, DDX1 and DDX3 function as cofactors that promote
replication of HIV (Fang et al., 2004; Yedavalli et al., 2004). DDX1
and DDX3 both appear to facilitate export of HIV RNA from thenucleus to the cytoplasm through interaction with Rev. DDX1 also
stimulates replication of coronavirus RNA (Xu et al., 2010).
However, because coronaviruses replicate in the cytoplasm, it
would appear that the role DDX1 plays in replication of these
large RNA viruses is distinct from its function as a cofactor
for HIV.
Yeast two hybrid and RNA interference screens have also
identiﬁed DEAD box helicases that play signiﬁcant roles in the
biology of ﬂavivirus infections (Ariumi et al., 2007; Krishnan et al.,
2008; Mamiya and Worman, 1999). Many of these enzymes likely
function in replication of viral RNA however recent evidence
suggests that helicases are needed for efﬁcient virus assembly too.
For example, we recently determined that the nucleolar helicase
DDX56 is needed for a critical post-replication step in WNV
morphogenesis (Xu et al., 2011). DDX56 appears to function in
assembly of pre-ribosomal particles, but it is not associated with
mature ribosomes (Zirwes et al., 2000). By analogy, it is tempting
to speculate that DDX56 functions similarly in assembly of other
large ribonucleoprotein particles such as viral nucleocapsids. The
fact that DDX56 is not detected in mature WNV virions (Xu et al.,
2011) is consistent with this scenario. A related study by another
laboratory revealed that DDX24 performs a similar function
during assembly of HIV virions (Ma et al., 2008).
DDX56 is not required for viability of cells in vitro (Xu et al.,
2011) and therefore, targeting the activity of this enzyme could
prove beneﬁcial in controlling WNV and potentially other ﬂavi-
virus infections. Rather than using RNAi to down-regulate expres-
sion of DDX56 in cells, it would be advantageous to use small
molecule inhibitors that target the enzymatic activity of this
Fig. 8. Expression of the capsid-binding region of DDX56 reduces infectivity of WNV. HEK293T cells were transduced with lentiviruses encoding AcGFP and myc-tagged
wild type (WT), N-terminal (NT) and C-terminal (CT) regions of DDX56. The next day, cells were infected with WNV and at 48 h post-infection, cell lysates and culture
supernatants were harvested. (A) Immunoblot analyses showing expression of myc-tagged DDX56 constructs (arrows), actin (loading control), AcGFP (transduction
efﬁciency indicator) and WNV capsid protein. Arrowheads indicate the positions of WT, NT and CT DDX56 constructs. (B) Plaque assay was used to determine the titers of
WNV secreted from cells transduced with lentiviruses encoding AcGFP alone (vector), WT DDX56, NT or CT constructs. (C) WNV virions secreted from HEK293T cells
transduced with lentiviruses encoding AcGFP alone (vector), DDX56 WT, NT or CT constructs were recovered by ultracentrifugation. The crude virion preparations were
subjected to SDS-PAGE and immunoblot analyses with rabbit anti-capsid antibody. The relative amounts of capsid from three independent experiments were quantitated
(A). (D) Levels of viral genomic RNA in the virions were determined by RT-PCR. The average relative levels of viral RNA (normalized to capsid protein) from three
independent experiments (each conducted in triplicate) were quantitated. Bars indicate standard error values.
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demonstrate that the helicase activity of DDX56 is in fact required
for its role in WNV infectivity. While this may seem intuitive, the
enzymatic function of a ‘‘helicase’’ is not always required for its
role in virus biology. Indeed, among highly related viral helicases,
the mode of action during virus assembly can vary greatly. For
example, assembly of infectious Kunjin virus, a close relative of
WNV, requires expression of the viral NS3 protein in cis (Liu et al.,
2002). In contrast, during assembly of yellow fever virus particles,
the helicase activity of NS3 is not required for this process (Patkar
and Kuhn, 2008). Moreover, yellow fever virus NS3 can perform
its virus assembly function when expressed in trans unlike Kunjin
virus NS3 which must be expressed in cis.
The helicase activity of DDX56 is not essential for replication or
assembly of WNV virions per se but our data indicate that it is
critical for infectivity of virus particles. Moreover, because over-
expression of the capsid-binding region of DDX56 has a similar
effect as reducing expression of DDX56 or knocking out its helicase
activity, we hypothesize that interaction between capsid and this
host enzyme facilitate loading and/or organization of viral RNA
during virus assembly. Through an unknown mechanism, WNV
infection causes relocalization of DDX56 from the nucleolus to
cytoplasmic structures that are enriched in capsid protein (Xu
et al., 2011). It is likely that these capsid-positive cytoplasmic
elements are virus assembly sites on the endoplasmic reticulum.
Next, it will be of interest to develop small molecule inhibitors that
can be used to target the helicase activity of DDX56. These inhibitors
would not be expected to block replication of WNV, but by reducing
the infectivity of nascent virions, viral spread would be minimized
thereby allowing the immune system to contain the infection.Materials and methods
General lab reagents
Laboratory reagents were purchased from the following sources:
CompleteTM EDTA-free protease inhibitor cocktail from Roche
Diagnostics (Laval, Quebec); Protein G-sepharose from GE Health-
care Bio-Sciences AB (Piscataway, NJ); Per-Fectin transfection
reagent from Genlantis (San Diego, CA); TransITs-293 transfection
regent from MirusBio (Madison, WI); Pierce BCA Protein Assay Kit
from Thermo Scientiﬁc (Rockford, IL); human full-length veriﬁed
DDX56 cDNA (Clone id 3456547) and human GIPZ lentiviral
shRNAmir individual clone (Clone id V3LHS_353980) targeting
DDX56 mRNA from Open Biosystems (Huntsville, AL); HEK 293T,
A549 and BHK21 cells from the American Type Culture Collection
(Manassas, VA); PerfeCTaTM SYBRs Green Supermix Low ROX from
Quanta Biosciences (Gaithersville, MD); SuperScript III reverse
transcriptase cDNA synthesis kit, random primers, ProLongs Gold
Anti-fade reagent with 40-6-diamidino-2-phenylindole (DAPI) and
all other reagents for mammalian cell culture were obtained from
Invitrogen (Carlsbad, CA).
Antibodies
Antibodies were obtained from the following sources: DDX56-
speciﬁc mouse monoclonal from PROGEN Biotechnik (Heidelberg,
Germany); rabbit and guinea pig polyclonal antibodies to WNV
capsid protein were generated in this laboratory (Hunt et al., 2007;
Xu et al., 2012); myc-speciﬁc mouse monoclonal antibodies were
puriﬁed from 9E10 hybridoma cells from ATCC (Manassas, VA);
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polyclonal antibody and nucleolin-speciﬁc rabbit antibodies from
Abcam (Cambridge, MA); green ﬂuorescent protein (GFP)-speciﬁc
rabbit polyclonal antibody from Dr. L. Berthiaume (University of
Alberta, Edmonton, Canada); goat anti-rabbit and goat anti-mouse
IgG conjugated to horseradish peroxidase from Jackson Immuno-
Research Laboratories (West Grove, PA); donkey anti-mouse IgG
conjugated to Alexa Fluor 546, donkey anti-rabbit IgG conjugated
to Alexa Fluor 647 and goat anti-guinea pig IgG conjugated to
Alexa Fluor 488 from Invitrogen (Carlsbad, CA).
Plasmids
All plasmids were constructed using PCR and standard sub-
cloning techniques. Prior to use in experiments, the newly
constructed plasmids were veriﬁed by diagnostic restriction
endonuclease digestion and DNA sequencing.
RNAi-resistant and DEAD box mutants of DDX56
Constructs encoding myc-tagged RNAi resistant forms of DDX56
were generated using the overlap extension PCR method. For the
ﬁrst PCR, the plasmid pcDNA3.1(-)-DDX56-myc (Xu, Anderson,
and Hobman, 2011) served as the template. Primer pairs used for
the ﬁrst PCR were NotI-F and RNAi-resistant-R and MluI-R and
RNAi-resistant-F (Table 1). The RNAi-resistant mutations were
designed based on the target sequence recognized by the DDX56-
speciﬁc shRNAmir-353980 targeting sequence as shown in Fig. 1.
The product of the overlap PCR which was ampliﬁed using primers
NotI-F and MluI-R was subcloned into the Not I and Mlu I sites of
pLVX-Tight-Puro to produce pLVX-DDX56-wt-RNAi-R. To generate
RNAi-resistant DEAD box mutants of DDX56, the wild type RNAi
resistant DDX56 cDNA produced as described above was subjected
to PCR using the primer pair NotI-F/MluI-R together with primers
that introduce mutations into the DEAD box motif (D166N-F and
D166N-R; E167Q-F and E167Q-R). The resulting cDNAs (D166N
and E167Q) were then subcloned into the Not I and Mlu I sites
of pLVX-Tight-Puro to produce pLVX-DDX56-D166N-RNAi-R and
pLVX-DDX56-E167Q-RNAi-R, respectively.
The cDNAs encoding RNAi-resistant wild type, D166N and
E167Q DDX56 were excised from the pLVX plasmids and sub-
cloned into the Spe I and Xho I sites of the lentiviral vectorTable 1
Oligonucleotide primers.
Primer name Sequence
NotI-F 5-ACT CGA GCG GCCGCC ACT GTG CTG GAT A
MluI-R 5-GCGTACGCGTTCACAGATCCTCTTCTGAGATGA
RNAi resistant-F 5-GCTGATATTACATAACCCAGTAACGCTCAAATT
GTCCCAGCTGCCTG-3
RNAi resistant-R 5-CAGGCAGCTGGGACTCCTGCAATTTGAGCGTT
ATGTAATATCAGC-3
D166N-F 5-GCTTTTGGTGGTGAACGAAGCTGACC-3
D166N-R 5-GGTCAGCTTCGTTCACCACCAAAAGC-3
E167Q-F 5-CTTTTGGTGGTGGACCAAGCTGACCTTC-3
E167Q-R 5-GAAGGTCAGCTTGGTCCACCACCAAAAG-3
SpeI-F 5-CTAT ACTAGTCCGCCACCATGGAGGACTCTG-
XhoI-R 5-CGGT CTCGAG TCA CAG ATC CTC TTC TGA G
SpeI-EcoRV-F 5-CTAT ACTAGT ACT GTG CTG GAT ATC TGC A
DDX56-F 5-CTATGAATTCGCCACCATGGAGGACTCTGAAG
DDX56-R 5-GCGTGGATCCGGAGGGCTTGGCTGTGGGTCTG
NT-R 5-GCGT GGA TCC AAG GGT AAC CGG GTT ATG
CT-F 5-CTATGAATTCGCCACCATGAAGTTACAGGAGT
WNV-env-F 5-TCA GCG ATC TCT CCA CCA AAG-3
WNV-env-R 5-GGG TCA GCA CGT TTG TCA TTG-3
Cyclophilin-F 5-TCC AAA GAC AGC AGA AAA CTT TCG-3
Cyclophilin-R 5-TCT TCT TGC TGG TCT TGC CAT TCC-3pTRIP-CMV-MCS-IRES-AcGFP. The resulting plasmids pTRIP-
AcGFP-DDX56-wt, D166N, and E167Q-RNAi-R, respectively, direct
independent expression of AcGFP and DDX56 wild type and
mutants. The plasmid pTRIP-AcGFP-DDX56-wt-RNAi-S (sensitive)
was created by ligation of a cDNA encoding wild type myc-tagged
DDX56 into the Spe I and Xho I sites of pTRIP-IRES-AcGFP.
Deletion mutants of DDX56
DNA fragments encoding myc-tagged amino acid residues
1–218 and 219–547 of DDX56 were generated by PCR with primers
pairs DDX56-F/DDX56-NT-R and DDX56-CT-F/DDX56-R, respec-
tively, using the plasmid pcDNA3.1(-)-DDX56-myc (Xu, Anderson,
and Hobman, 2011) as template. The resulting cDNAs were ligated
into the EcoR I and BamH I sites of the mammalian expression
vector pcDNA3.1(-)-myc. Myc-tagged DDX56-NT and DDX56-CT
cDNAs produced by PCR using primers SpeI-EcoRV-F and XhoI-R
were also ligated into the Spe I and Xho I sites of the lentiviral
vector pTRIP-CMV-MCS-IRES-AcGFP.
Construction of the mammalian expression plasmid encoding
the 105 amino acid isoform of WNV capsid, pCMV5-Capsid, has
been described previously (Hunt et al., 2007).
Cell culture and transfection
HEK293T and A549 cells were cultured in DMEM supplemented
with 100 U/ml penicillin/streptomycin, 10% heat-inactivated fetal
bovine serum and 10 mM HEPES, pH 7.4, at 37 1C and 5% CO2. DNA
transfections were performed using Perfectin or TransITs-293
transfection reagent as described by the manufacturers.
Indirect immunoﬂuorescence
A549 cells grown on coverslips were transfected with plasmids
encoding myc-tagged full length and truncation DDX56 con-
structs. At 24 h post-transfection, cells were infected with WNV
(MOI¼5) for 24 h and then ﬁxed and processed for indirect
immunoﬂuorescence microscopy. Coverslips were mounted onto
microscope slides using ProLong Gold antifade reagent with DAPI,
after which the samples were examined using a Leica TCS SP5
confocal microscope. In all cases, samples were viewed using
63 objective lens and images were acquired using identicalRestriction enzyme site Usage
TC-3 Not I Cloning
G-3 Mlu I Cloning
GCAGGA Cloning
ACTGGGTT Cloning
Cloning
Cloning
Cloning
Cloning
3 Spe I Cloning
-3 Xho I Cloning
G-3 SpeI, EcoR V Cloning
CACTG-3 EcoR I Cloning
-3 BamH I Cloning
TAA-3 BamH I Cloning
CCCAG-3 EcoR I Cloning
qRT-PCR
qRT-PCR
qRT-PCR
qRT-PCR
Z. Xu, T.C. Hobman / Virology 433 (2012) 226–235234exposure times for each channel. Images were processed using
Image J and LAS AF Lite software.
Coimmunoprecipitation and GST pull-down
HEK293T cells (1.2106) were seeded into 100-mm-diameter
dishes and the next day, were transfected with expression
plasmids (8 mg) using PerFectin. After 48 h, cells were washed
with phosphate-buffered saline (PBS) and then lysed with NP-40
lysis buffer (150 mM NaCl, 2 mM EDTA, 1% non-idet P-40, 50 mM
Tris–HCl [pH 7.2], 1 mM fresh dithiothreitol) containing protease
inhibitors on ice for 30 min. Lysates were clariﬁed by centrifuga-
tion for 10 min at 14,000 rpm in a microcentrifuge at 4 1C. Small
aliquots of the clariﬁed lysates were kept for loading controls. The
remaining lysates were precleared with Protein A- or G-Sepharose
beads for 1 h at 4 1C before sequential incubation with mouse
anti-myc antibodies for 3 h and then Protein A- or G-Sepharose
beads for 2 h at 4 1C. For the GST pull-down experiments, cleared
lysates were incubated with glutathione-Sepharose 4B beads for
2 h at 4 1C. Immunoprecipitates and GST pull-downs were washed
three times with lysis buffer before the bound proteins were
eluted by boiling in protein sample buffer. Proteins were sepa-
rated by SDS-PAGE and transferred to polyvinylidene diﬂuoride
membranes for immunoblotting.
Stable knockdown of DDX56 in HEK293T cells
Stable HEK293T cell lines expressing a DDX56-speciﬁc (Clone
id V3LHS_353980 Open Biosystems) or a non-silencing shRNAmir
(catalog number RHS4346; Open Biosystems) were created by
lentiviral transduction followed by puromycin selection (1 mg/ml)
as described (Xu et al., 2011). After selection, the resulting
polyclonal cell lines were maintained in media containing
0.25 mg/ml puromycin.
Production of lentiviruses for expression of DDX56 mutants
HEK293T cells (2.5106) in 100 mm dishes were co-
transfected with pTRIP-AcGFP plasmids encoding myc-tagged
DDX56 cDNAs (WT, D166N, E167Q, NT or CT), pGag-Pol (5.6 mg)
and pHCMV-VSVG (1.6 mg) using TransITs-293 transfection
reagent. Forty-eight hours later, polybrene (4 mg/ml) and HEPES
(20 mM) were added to the lentivirus-containing culture super-
natants which were then passed through 0.45 mm ﬁlter before
aliquotting. Stocks were stored at 80 1C or used immediately to
transduce HEK293T or A549 cells. Typically, lentiviral stocks were
diluted 1:10 in DMEM containing 3% FBS, polybrene (4 mg/ml) and
HEPES (20 mM). Cells were then spinoculated by centrifugation at
1200 rpm in an Eppendorf A-4-62 rotor for 1 h at 37 1C after
which the plates were transferred to a 37 1C incubator. After 6 h,
the media were replaced with DMEM containing 10% FBS. Unless
otherwise indicated, transduced cells were analyzed 48 h post-
transduction.
WNV infection
WNV strain NY99 was kindly provided by Mike Drebot (Public
Health Agency of Canada, Winnipeg, MB). All virus manipulations
were performed under level 3 containment conditions. Unless
otherwise indicated, cultured cells were infected using an MOI of
5. Plaque assays were conducted using BHK21 cells as described
(Xu et al., 2011).
To recover WNV particles from infected cells, medium from
infected cells was precleared of cell debris by centrifugation
for 10 min at 2500  g, after which the resulting supernatants
were passed through 0.45-mm ﬁlters. Virus was inactivated byexposure to ultraviolet light in a biosafety cabinet for 1 h prior to
removal of the material out of the level 3 facility. WNV virions
were then recovered from the clariﬁed medium by centrifugation
at 100,000  g for 1 h.
Quantitative PCR analysis of viral RNA
Total RNA from crude WNV virion preparations was isolated
with TRIzols reagent (Invitrogen) according to the manufac-
turer’s instructions. Reverse transcription and quantitative PCR
analyses of WNV genomic RNA was performed as described (Xu
et al., 2011). The relative amount of WNV genomic RNA in each
sample was normalized to the amount of capsid protein which
was determined by immunoblotting.Acknowledgments
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